Neuroscience News, Articles | Today's Clinical Lab

The consortium includes data from more than 35,000 biofluid samples, leading to approximately 250 million unique protein measurements.

Global Neurodegeneration Proteomics Atlas Reveals Key Disease Signatures

Zahraa Chorghay, PhD

A global harmonized proteomics dataset of Alzheimer’s, Parkinson’s, and FTD uncovers disease signatures to accelerate diagnostics and therapeutic discovery

The Octave MSDA Test is the first and only clinically and analytically validated multi-analyte blood test that reports an MS disease activity score.

Nationwide Access to New Multi-Analyte Laboratory Test for Multiple Sclerosis

Quest Diagnostics, Octave Bioscience

Collaboration brings new hope for patients with multiple sclerosis through expanded access to a clinically validated multi-analyte blood test

Addressing the complex biology of progression is a major challenge in managing MS patients.

Capturing the Elusive: Why Multi-Protein Biomarkers Tests Are the Future of Measuring MS Progression

Ferhan Qureshi

Exploring how precision biomarkers can reveal hidden disease dynamics and drive a new standard of MS care

The study underscores the urgent need to better understand the health consequences of plastic pollution.

Scientists Discover How Nanoplastics Disrupt Brain Energy Metabolism

Trinity College Dublin

The findings provide fresh insights into the potential health risks posed by environmental plastics

Vaccination remains the best prevention against life-threatening complications like influenza-associated acute necrotizing encephalopathy.

Rapid Treatment Improves Outcomes in Children with Rare Flu Brain Complication

Today's Clinical Lab

Study highlights the critical need for early intensive care in influenza-associated acute necrotizing encephalopathy, a severe brain swelling condition

Illustration of the human brain showing normal pressure hydrocephalus.

Minimally Invasive Approach Could Change Standard of Care for Normal Pressure Hydrocephalus

Dan Levangie

New treatments are moving away from open surgery and toward minimally invasive techniques

Illustration of white puzzle pieces arranged in the shape of a human head with pieces in the middle of the brain area missing and scattered across a blue background.

Targeted Treatment Breakthrough for Aggressive Childhood Brain Cancer

Today's Clinical Lab

New research identifies a critical genetic variation in Group 3 medulloblastomas, paving the way for improved diagnostic and treatment strategies for this challenging form of pediatric brain cancer